rs12423412
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002907.4(RECQL):c.-45-92C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 623,600 control chromosomes in the GnomAD database, including 17,247 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002907.4 intron
Scores
Clinical Significance
Conservation
Publications
- RECON progeroid syndromeInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RECQL | NM_002907.4 | c.-45-92C>T | intron_variant | Intron 1 of 14 | ENST00000444129.7 | NP_002898.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RECQL | ENST00000444129.7 | c.-45-92C>T | intron_variant | Intron 1 of 14 | 2 | NM_002907.4 | ENSP00000416739.2 |
Frequencies
GnomAD3 genomes AF: 0.188 AC: 28632AN: 151984Hom.: 3279 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.236 AC: 111172AN: 471498Hom.: 13964 AF XY: 0.237 AC XY: 59189AN XY: 249480 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.188 AC: 28640AN: 152102Hom.: 3283 Cov.: 33 AF XY: 0.191 AC XY: 14228AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at